We have observed
9 EP applications
Vinca Raymonde Lardans
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after December 16, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
COMBINATION THERAPY COMPRISING A CDK4/6 INHIBITOR AND A PI3K INHIBITOR FOR USE IN THE TREATMENT OF CANCER
COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE
PHARMACEUTICAL COMBINATION COMPRISING BINIMETINIB
ORAL FORMULATIONS OF DEFERASIROX
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK AND PIM